{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:27:05Z","timestamp":1792175225413,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jacc.2020.05.015","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T15:51:18Z","timestamp":1593445878000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":205,"title":["Baroreflex Activation Therapy in Patients With Heart\u00a0Failure With Reduced Ejection Fraction"],"prefix":"10.1016","volume":"76","author":[{"given":"Michael R.","family":"Zile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.05.015_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.05.015_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/eurheartj\/ehi446","article-title":"How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts","volume":"27","author":"McAlister","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.05.015_bib4","first-page":"2105","article-title":"Ventricular functional response to spinal cord stimulation for advanced heart failure: primary results of the randomized DEFEAT-HF Trial","volume":"130","author":"Zipes","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.05.015_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","article-title":"Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart\u00a0Failure (NECTAR-HF) randomized controlled trial","volume":"36","author":"Zannad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.05.015_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jacc.2016.03.525","article-title":"Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial","volume":"68","author":"Gold","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib7","first-page":"487","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.05.015_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cardfail.2010.09.004","article-title":"Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction","volume":"17","author":"Georgakopoulos","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2020.05.015_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11886-012-0265-y","article-title":"Baroreflex activation for the treatment of heart failure","volume":"14","author":"Sabbah","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2020.05.015_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11897-016-0286-8","article-title":"Baroreflex activation therapy in heart failure with reduced ejection fraction: available data and future perspective","volume":"13","author":"Halbach","year":"2016","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacc.2020.05.015_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/HYPERTENSIONAHA.107.095216","article-title":"Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure","volume":"50","author":"Zucker","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.05.015_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCHEARTFAILURE.110.955013","article-title":"Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure","volume":"4","author":"Sabbah","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2020.05.015_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FJC.0000000000000135","article-title":"Carotid baroreceptor stimulation prevents arrhythmias induced by acute myocardial infarction through autonomic modulation","volume":"64","author":"Liao","year":"2014","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2020.05.015_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00392-010-0249-0","article-title":"Baroreflex activation as a novel therapeutic strategy for diastolic heart failure","volume":"100","author":"Brandt","year":"2011","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/europace\/eut403","article-title":"Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies","volume":"16","author":"Madershahian","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2020.05.015_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ejhf.138","article-title":"Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study","volume":"16","author":"Gronda","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2020.05.015_bib17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ejhf.299","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy","volume":"17","author":"Zile","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2020.05.015_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semtcvs.2016.04.017","article-title":"Surgical experience and long-term results of baroreflex activation therapy for heart failure with reduced ejection fraction","volume":"28","author":"Weaver","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2020.05.015_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ahj.2018.07.011","article-title":"First granted example of novel FDA trial design under expedited access pathway for premarket approval: BeAT-HF","volume":"204","author":"Zile","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2020.05.015_bib21","article-title":"Expedited access for premarket approval and de novo medical devices intended for unmet medical need for life threatening or irreversibly debilitating diseases or conditions; guidance for industry and Food and Drug Administration staff; availability","year":"2015","journal-title":"Federal Register"},{"key":"10.1016\/j.jacc.2020.05.015_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCHEARTFAILURE.111.962654","article-title":"Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial","volume":"4","author":"Anand","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2020.05.015_bib23","first-page":"241","article-title":"Interaction between spironolactone and natriuretic peptides in patients with heart failure and preserved ejection fraction: from the TOPCAT trial","volume":"5","author":"Anand","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2020.05.015_bib24","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2009.06.041","volume":"54","author":"Cleland","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.05.015_bib26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition compared with enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.05.015_bib27","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib28","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.jacc.2016.09.936","article-title":"Natriuretic peptides, 6-min walk test, and quality-of-life questionnaires as clinically meaningful endpoints in HF trials","volume":"68","author":"Ferreira","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.05.015_bib29","first-page":"158","article-title":"NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF","volume":"7","author":"Daubert","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720352980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720352980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:33:57Z","timestamp":1760016837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720352980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0735109720352980"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.05.015","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baroreflex Activation Therapy in Patients With Heart\u00a0Failure With Reduced Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}